Amedica Corporation (NASDAQ:AMDA) Files An 8-K Submission of Matters to a Vote of Security HoldersItem 5.07 Submission of Matters to a Vote of Security Holders
On June 28, 2018, Amedica Corporation (the “Company”) held its annual meeting of stockholders at which the following matters were voted on:
Proposal No. 1: A proposal to elect two Class III directors to hold office for a term expiring at the annual meeting of stockholders to be held in 2020 or until their respective successors are elected and qualified. This proposal was approved.
|Nominee||Votes For||Votes Withheld||Broker Non-vote|
|B. Sonny Bal, M.D.||507,234||241,429||3,084,909|
|Jeffrey S. White||509,983||238,680||3,084,909|
There were no abstentions with respect to the election of directors.
Proposal No. 2: A proposal to ratify the appointment of Tanner LLC as the Company’s independent registered public accounting firm for the year ending December 31, 2018. This proposal was ratified.
About Amedica Corporation (NASDAQ:AMDA)
Amedica Corporation is a commercial biomaterial company. The Company is a vertically integrated silicon nitride orthopedic medical device manufacturer. It is focused on using its silicon nitride ceramic technology platform to develop, manufacture and sell a range of medical devices. It is also engaged in developing wear- and corrosion-resistant implant components for hip and knee arthroplasty. The Company markets its Valeo family of silicon nitride interbody spinal fusion devices in the United States, Europe and Brazil for use in the cervical and thoracolumbar areas of the spine. In addition to its silicon nitride-based spinal fusion products, it markets a line of non-silicon nitride spinal surgery products, which allows the Company to provide surgeons and hospitals with a solution for spinal procedures. Its Valeo interbody spinal fusion devices include Anterior Lumbar, Posterior Lumbar, Oblique Lumbar, Transforaminal Lumbar, Lateral Lumbar, Cervical and Corpectomy.